Home Monitoring, Thoracic Surgery
Conditions
Brief summary
To assess the feasibility of evaluating postoperative home monitoring with Biobeat digital monitoring. The investigators hypothesize that the Biobeat digital home monitoring platform will lead to a decrease in unplanned visits to the ED (Emergency Department). In addition, patients' quality of life is postulated to be improved compared to patients receiving the current standard of care without home monitoring.
Detailed description
This trial will be a single centre, parallel arm, randomized controlled feasibility trial. The investigators will evaluate postoperative home monitoring with the Biobeat digital monitoring and two-way communication through the digital portal for 4 weeks post-operatively to the standard of care (no digital monitoring) in thoracic surgery patients undergoing elective thoracic surgical procedures. The investigators will assess whether conducting a larger randomized trial of digital home monitoring vs. standard of care is feasible in terms of recruitment, data collection and logistics.
Interventions
Once patients are ready for discharge, patients in the digital group will be sent home with the Biobeat digital monitoring kit with written & oral instructions on how it will be used in maintaining continuity of care which will track ECG (electrocardiogram), HR, NIBP, SPO2, and pain scores. A continuous recording and two-lead ECG patch will be applied and activated at the time of discharge to identify any paroxysmal atrial fibrillation.
Sponsors
Study design
Eligibility
Inclusion criteria
* Patient willing to provide informed consent * Wi-fi or cellular connectivity at the patient's home * Patient undergoing elective lung cancer surgery * Patient familiar/comfortable with the use of technology such as online banking.
Exclusion criteria
\- Patients who are not comfortable with the use of technology.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| To assess whether conducting a larger randomized trial of digital home monitoring vs. standard of care is feasible in terms of recruitment, data collection and logistics. | 365 days | The trial will be deemed feasible if \>/= 60% of eligible patients are recruited, \>/= 80% of data is collected, and \</= 20% of patients are lost to follow-up. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Number of ED Visits | 30 days from discharge | Number of ED visits |
| Readmission Rates | 30 days from discharge | Number of readmissions |
Countries
Canada